Pericyazine 10mg tablets

Land: Storbritannia

Språk: engelsk

Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiv ingrediens:

Pericyazine

Tilgjengelig fra:

DE Pharmaceuticals

ATC-kode:

N05AC01

INN (International Name):

Pericyazine

Dosering :

10mg

Legemiddelform:

Oral tablet

Administreringsrute:

Oral

Klasse:

No Controlled Drug Status

Resept typen:

Valid as a prescribable product

Produkt oppsummering:

BNF: 04020100

Informasjon til brukeren

PACKAGE LEAFLET:
INFORMATION FOR THE USER
PERICYAZINE 10MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE

Keep this leaflet. You may need to read it again

If you have any further questions, ask your doctor or pharmacist

This medicine has been prescribed for you. Do not pass it on to
others. It may harm them,
even if their symptoms are the same as yours.

If any of the side effects gets serious, or if you notice any side
effects not listed in this
leaflet, please tell your doctor or pharmacist
IN THIS LEAFLET:
1. What pericyazine is and what it is used for
2. Before you take pericyazine
3. How to take pericyazine
4. Possible side effects
5. How to store pericyazine
6. Further Information
1. WHAT PERICYAZINE IS AND WHAT IT IS USED FOR
1.
The name of your medicine is Pericyazine 10mg Tablets (referred to as
pericyazine throughout
this leaflet).This belongs to a group of medicines called
‘phenothiazines’. It works by blocking the
effect of a chemical in the brain.
It can be used for:

Schizophrenia

The short term treatment of anxiety, agitation and violent or
dangerously impulsive
behaviour when used with other medicines
2. BEFORE YOU TAKE PERICYAZINE
DO NOT TAKE THIS MEDICINE AND TELL YOUR DOCTOR IF:

You are allergic (hypersensitive) to pericyazine or any of the other
ingredients in this
medicine (listed in Section 6)
Signs of an allergic reaction include: a rash, swallowing or breathing
problems, swelling
of your lips, face, throat or tongue

You are pregnant, might become pregnant or think you may be pregnant
(see Section
below: ‘Pregnancy and breast-feeding’)
Do not take this medicine if any of the above apply to you. If you are
not sure, talk to your doctor
or pharmacist before taking pericyazine.
TAKE SPECIAL CARE WITH PERICYAZINE
CHECK WITH YOUR DOCTOR OR PHARMACIST BEFORE YOU TAKE THIS MEDICINE IF:

You have heart problems or a family history of heart problems

You have ever had a stroke

You have liver or kidney problems

You hav

Preparatomtale

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Pericyazine 10mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pericyazine 10mg
Excipients with known effect:
Methyl hydroxybenzoate: Each 10mg tablet contains 0.003 mg benzoate
salt.
Lactose: Each 10mg tablet contains 112.5mg lactose.
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Pericyazine 10mg Tablets: Circular, very pale lime-yellow tablet, with
one
face impressed ‘S172’ and a break-line on reverse.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
a)
In adults with schizophrenia or other psychoses, for the treatment of
symptoms or
prevention of relapse.
b)
In anxiety, psychomotor agitation, violent or dangerously impulsive
behaviour.
Pericyazine is used as an adjunct to the short-term management of
these conditions.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Route of administration_: oral .
Dosage requirement varies with the individual and the severity of the
condition being
treated. Initial dosage should be low with progressive increases until
the desired
response is obtained, after which dosage should be adjusted to
maintain control of the
symptoms.
_ Severe conditions _
_Indication (a) _
_ _
Adults:_ _Initially 75 mg per day in divided doses. Dosage should be
increased
by 25 mg per day at weekly intervals until the optimum effect is
achieved.
Maintenance therapy would not normally be expected to exceed 300 mg
per
day.
Elderly: _ _Initially 15-30 mg per day in divided doses. If this is
well tolerated
the dosage may be increased if necessary for optimum control of
behaviour.
_Mild or moderate conditions _
_ _
_Indication (b) _
_ _
Adults: Initially 15-30 mg daily, divided into two portions with a
larger dose
being given in the evening.
Elderly: 5-10 mg per day is suggested as a starting dose. It may be
divided so
that a larger portion is given in the evening. Half or quarter the
normal adult
dose may be sufficient for maintenance therapy.
Pericyazine tablets are not recommended for children.
4.3
CONTRAINDI